Kabra Drugs Ltd intimated a board meeting on 21st April 2026 to consider major business diversification into six new sectors including drones, healthcare, and AI.
The board will consider appointing Ms. Monam Kapoor as an Additional Director (Non-Executive Independent) and approve a postal ballot process for these matters.
The company proposed amendments to its Memorandum of Association to include manufacturing and distribution across defence, dairy, agro products, and hospitality sectors.